MWG.F

Healthcare Drug Manufacturers - Specialty & Generic

InMed Pharmaceuticals Inc.

€1.13

+0.02 +1.80% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 11:36 AM ET	1.13

Key Stats

Market Cap

6.21M

Avg Volume

EPS

-€2.43

52W High

€2.06

52W Low

€0.47

Div. Yield

0.0%

Valuation

P/B Ratio

6.45

EV/EBITDA

-0.40

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(156.8%)

Return on Assets

(66.5%)

Liquidity & Leverage

Current Ratio

1.37

Quick Ratio

1.14

Total Cash

2.23M

Total Debt

About

InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.